Portal de Periódicos da CAPES

SQSTM1 Mutations in French Patients With Frontotemporal Dementia or Frontotemporal Dementia With Amyotrophic Lateral Sclerosis

2013; American Medical Association; Linguagem: Inglês

10.1001/jamaneurol.2013.3849

2168-6157

Isabelle Le Ber, Agnès Camuzat, Rita Guerreiro, Kawtar Bouya-Ahmed, José Brás, Gaël Nicolas, Audrey Gabelle, Mira Didic, Anne de Septenville, Stéphanie Millecamps, Timothée Lenglet, Morwena Latouche, Edor Kabashi, Dominique Campion, Didier Hannequin, John Hardy, Alexis Brice,

Cholinesterase and Neurodegenerative Diseases

Mutations in the SQSTM1 gene, coding for p62, are a cause of Paget disease of bone and amyotrophic lateral sclerosis (ALS). Recently, SQSTM1 mutations were confirmed in ALS, and mutations were also identified in 3 patients with frontotemporal dementia (FTD), suggesting a role for SQSTM1 in FTD.To evaluate the exact contribution of SQSTM1 to FTD and FTD with ALS (FTD-ALS) in an independent cohort of patients.A SQSTM1 mutation was first identified in a multiplex family with FTD by use of whole-exome sequencing. To evaluate the frequency of SQSTM1 mutations, we sequenced this gene in a cohort of patients with FTD or FTD-ALS, with no mutations in known FTD and ALS genes.Primary care or referral center.An overall cohort of 188 French patients, including 132 probands with FTD and 56 probands with FTD-ALS.Frequency of SQSTM1 mutations in patients with FTD or FTD-ALS; description of associated phenotypes.We identified 4 heterozygous missense mutations in 4 unrelated families with FTD; only 1 family had clinical symptoms of Paget disease of bone, and only 1 family had clinical symptoms of FTD-ALS, possibly owing to the low penetrance of some of the clinical manifestations.Although the frequency of the mutations is low in our series (4 of 188 patients [2%]), our results, similar to those already reported, support a direct pathogenic role of p62 in different types of FTD.